Dr Saral Thangam, Managing Director of Alvogen‘s subsidiary, Norwich Clinical Services in Bangalore, India, has been featured in a recent issue of Biospectrum Magazine.
The feature was titled "Influential women in bioscience industry" and profiled several female CEOs, CSOs, directors, regulators, entrepreneurs, vice presidents and scientific researchers in this this traditionally male-dominated industry in India.
"I was thrilled to be listed among these talented women in India for this feature", commented Dr Thangam. "It is a pleasure to see how many outstanding women are making inroads into this niche sector and it is my hope that in another decade we will see even more."
Norwich Research was set up in Bangalore in 2010 and has pharmacovigilance, biostudy and clinical trial capabilities. It is a contract research organization owned by Alvogen. It employs 110 staff qualified in different therapeutic areas. The CRO is certified by Indian DCGI and the Brazilian Agency ANVISA and has completed studies for USFDA, EU and WHO at its site.